United States Diagnostics Market, By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others), By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others), By Usability (Reusable v/s Disposable), By Application (Infectious Diseases (Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19), Cancer, Sexually Transmitted Diseases, Others), By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026
United States diagnostics market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period. The United States diagnostics market is driven by the growing prevalence of various chronic and infectious diseases. Additionally, increasing awareness among the population pertaining to healthcare is further expected to propel the market growth. Besides, supportive government policies & schemes such as Patient Protection & Affordable Care Act, Medicare and Medicaid are further expected to positively influence the market growth through 2026. Furthermore, increasing investment on R&D and new product or instruments/techniques launches by the major players is expected to create lucrative opportunities for market growth over the next few years. Moreover, the sudden outbreak and spread of pandemic COVID-19 within the country has drastically increased the demand for infectious disease testing diagnostic tests and procedures being carried out. It has also increased the demand for rapid test kits which can help in the diagnosis of disease, thereby fueling the market growth.
The United States diagnostics market is segmented based on product type, type of test, technique, usability, application, end user, company and region. Based on product type, the market can be categorized into reagents, instruments and software & services. Among these, the reagents segment dominated the market in 2020 with a share of around 54.35%. This is expected to continue its dominance over the forecast period as well. This can be attributed to the fact that reagents form an integral part of a diagnostic procedure or test, and no laboratory-based diagnostic procedure or test can be performed without the use of reagents. Additionally, the growing demand for rapid and accurate diagnostics is further expected to fuel the segmental growth. Furthermore, an increase in demand for self-testing and point-of-care testing is expected to spur the growth of reagents. Besides, increasing research & development pertaining to reagents is expected to create lucrative opportunities for the market growth. The software & service segment is expected to hold a significant market share owing to the growing preference for accurate, reliable and efficient diagnostic software.
Regionally, the market can be categorized into North-East, Mid-West, West and South. Among these, the Southern region in the United States is expected to dominate the overall diagnostics market with a share of around 33.86% in 2020 and is expected to continue maintaining its dominance over the forecast period as well. This can be attributed to the high population density, growing industrialization and increasing establishment of industries and factories in the region. This in turn increases the susceptibility of the population to various chronic and infectious diseases especially respiratory problems, thereby driving the market growth in the region.
Major players operating in the United States diagnostics market include Abbott Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson & Johnson, Ortho-Clinical Diagnostics, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Biomerieux Inc. and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.
Years considered for this report:
TechSci Research calculated the market size of United States diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
Report Scope:
In this report, United States diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in United States diagnostics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
The United States diagnostics market is segmented based on product type, type of test, technique, usability, application, end user, company and region. Based on product type, the market can be categorized into reagents, instruments and software & services. Among these, the reagents segment dominated the market in 2020 with a share of around 54.35%. This is expected to continue its dominance over the forecast period as well. This can be attributed to the fact that reagents form an integral part of a diagnostic procedure or test, and no laboratory-based diagnostic procedure or test can be performed without the use of reagents. Additionally, the growing demand for rapid and accurate diagnostics is further expected to fuel the segmental growth. Furthermore, an increase in demand for self-testing and point-of-care testing is expected to spur the growth of reagents. Besides, increasing research & development pertaining to reagents is expected to create lucrative opportunities for the market growth. The software & service segment is expected to hold a significant market share owing to the growing preference for accurate, reliable and efficient diagnostic software.
Regionally, the market can be categorized into North-East, Mid-West, West and South. Among these, the Southern region in the United States is expected to dominate the overall diagnostics market with a share of around 33.86% in 2020 and is expected to continue maintaining its dominance over the forecast period as well. This can be attributed to the high population density, growing industrialization and increasing establishment of industries and factories in the region. This in turn increases the susceptibility of the population to various chronic and infectious diseases especially respiratory problems, thereby driving the market growth in the region.
Major players operating in the United States diagnostics market include Abbott Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson & Johnson, Ortho-Clinical Diagnostics, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Biomerieux Inc. and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.
Years considered for this report:
- Historical Years: 2016-2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022-2026
- To analyze the historical growth in the market size of United States diagnostics market from 2016 to 2020.
- To estimate and forecast the market size of United States diagnostics market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast United States diagnostics market based on product type, type of test, technique, usability, application, end user, company and regional distribution.
- To identify dominant region or segment in the United States diagnostics market.
- To identify drivers and challenges for United States diagnostics market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States diagnostics market.
- To identify and analyze the profile of leading players operating in United States diagnostics market.
- To identify key sustainable strategies adopted by market players in United States diagnostics market.
TechSci Research calculated the market size of United States diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Hospitals, public labs, diagnostic centers and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to diagnostics
- Market research and consulting firms
Report Scope:
In this report, United States diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- United States Diagnostics Market, By Product Type:
- Reagents
- Instruments
- Software & Services
- United States Diagnostics Market, By Type of Test:
- Infectious Disease Testing
- Lipid Panel
- Metabolic Panel
- Others
- United States Diagnostics Market, By Technique:
- Immunodiagnostics
- Clinical Techniques
- Molecular Diagnostics
- Tissue Diagnostics
- Others
- United States Diagnostics Market, By Usability:
- Reusable
- Disposable
- United States Diagnostics Market, By Application:
- Infectious Diseases
- Human Papillomavirus
- Hepatitis
- Tuberculosis
- Hospital-Acquired Infections
- COVID-19
- Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Liver Cancer
- Others
- Sexually Transmitted Diseases
- Chlamydia Trachomatis Infection
- Gonorrhoea
- Syphilis
- Others
- Others
- United States Diagnostics Market, By End User:
- Hospitals & Clinics
- Diagnostic Centers
- Point-of-Care Testing Centers
- Private or Commercial Laboratories
- Others
- United States Diagnostics Market, By Region:
- South
- Mid-West
- West
- North-East
Company Profiles: Detailed analysis of the major companies present in United States diagnostics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UNITED STATES DIAGNOSTICS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Brand Awareness
5.2. Reasons for Getting Diagnostics Test Done
5.3. Preferred Choice of Setup for Getting Diagnostic Test
6. UNITED STATES DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Reagents, Instruments, Software & Services)
6.2.2. By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others)
6.2.3. By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others)
6.2.4. By Usability (Reusable v/s Disposable)
6.2.5. By Application (Infectious Diseases (Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19), Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Liver Cancer, Others), Sexually Transmitted Diseases (Chlamydia Trachomatis Infection, Gonorrhoea, Syphilis, Others), Others)
6.2.6. By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others)
6.2.7. By Company (2020)
6.2.8. By Region
6.2.9. Company-wise List of major testing diagnostics kits approved
6.3. Market Map
7. UNITED STATES INFECTIOUS DISEASE TESTING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technique
7.2.3. By Usability
7.2.4. By Application
7.2.5. By End User
7.2.6. By Region
8. UNITED STATES LIPID PANEL TEST MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technique
8.2.3. By Usability
8.2.4. By Application
8.2.5. By End User
8.2.6. By Region
9. UNITED STATES METABOLIC PANEL TEST MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technique
9.2.3. By Usability
9.2.4. By Application
9.2.5. By End User
9.2.6. By Region
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. US ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Abbott Laboratories, Inc.
14.2. Danaher Corporation
14.3. Thermo Fisher Scientific, Inc.
14.4. Johnson & Johnson
14.5. Ortho-Clinical Diagnostics, Inc.
14.6. Becton, Dickinson, and Company
14.7. Bio-Rad Laboratories, Inc.
14.8. Roche Diagnostics Corporation
14.9. Siemens Medical Solutions USA, Inc.
14.10. Biomerieux Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON UNITED STATES DIAGNOSTICS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Brand Awareness
5.2. Reasons for Getting Diagnostics Test Done
5.3. Preferred Choice of Setup for Getting Diagnostic Test
6. UNITED STATES DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Reagents, Instruments, Software & Services)
6.2.2. By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others)
6.2.3. By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others)
6.2.4. By Usability (Reusable v/s Disposable)
6.2.5. By Application (Infectious Diseases (Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19), Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Liver Cancer, Others), Sexually Transmitted Diseases (Chlamydia Trachomatis Infection, Gonorrhoea, Syphilis, Others), Others)
6.2.6. By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others)
6.2.7. By Company (2020)
6.2.8. By Region
6.2.9. Company-wise List of major testing diagnostics kits approved
6.3. Market Map
7. UNITED STATES INFECTIOUS DISEASE TESTING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technique
7.2.3. By Usability
7.2.4. By Application
7.2.5. By End User
7.2.6. By Region
8. UNITED STATES LIPID PANEL TEST MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technique
8.2.3. By Usability
8.2.4. By Application
8.2.5. By End User
8.2.6. By Region
9. UNITED STATES METABOLIC PANEL TEST MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technique
9.2.3. By Usability
9.2.4. By Application
9.2.5. By End User
9.2.6. By Region
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. US ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. Abbott Laboratories, Inc.
14.2. Danaher Corporation
14.3. Thermo Fisher Scientific, Inc.
14.4. Johnson & Johnson
14.5. Ortho-Clinical Diagnostics, Inc.
14.6. Becton, Dickinson, and Company
14.7. Bio-Rad Laboratories, Inc.
14.8. Roche Diagnostics Corporation
14.9. Siemens Medical Solutions USA, Inc.
14.10. Biomerieux Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
LIST OF TABLES
Table 1: United States COVID-19 Statistics, As of 12th May 2020
Table 2: State-Wise List of Hospitals in the United States, As of 2020
Table 3: Company-Wise List of Major Testing Kits Approved
Table 4: United States Estimated Number of New Cancer Cases of Respiratory System and Subsequent Deaths, 2020
Table 5: United States Total Number of Hospitals, 2019
Table 6: United States Estimated Number of New Cancer Cases of Respiratory System and Subsequent Deaths, Female, 2020
Table 7: United States Estimated New Cases for Lung & Bronchus Cancers by Most Affected States, 2020
Table 8: United States Estimated Number of New Cancer Cases of Respiratory System and Subsequent Deaths, Male, 2020
Table 1: United States COVID-19 Statistics, As of 12th May 2020
Table 2: State-Wise List of Hospitals in the United States, As of 2020
Table 3: Company-Wise List of Major Testing Kits Approved
Table 4: United States Estimated Number of New Cancer Cases of Respiratory System and Subsequent Deaths, 2020
Table 5: United States Total Number of Hospitals, 2019
Table 6: United States Estimated Number of New Cancer Cases of Respiratory System and Subsequent Deaths, Female, 2020
Table 7: United States Estimated New Cases for Lung & Bronchus Cancers by Most Affected States, 2020
Table 8: United States Estimated Number of New Cancer Cases of Respiratory System and Subsequent Deaths, Male, 2020
LIST OF FIGURES
Figure 1: United States Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 2: United States Diagnostics Market Share, By Product Type, By Value, 2016-2026F
Figure 3: United States Diagnostics Market Share, By Type of Test, By Value, 2016-2026F
Figure 4: United States Diagnostics Market Share, By Technique, By Value, 2016-2026F
Figure 5: United States Diagnostics Market Share, By Usability, By Value, 2016-2026F
Figure 6: United States Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 7: United States Diagnostics Market Share, By Application, By Infectious Diseases, By Value, 2016-2026F
Figure 8: United States Diagnostics Market Share, By Application, By Cancer, By Value, 2016-2026F
Figure 9: New Cancer Cases Reported in the United States in 2020, both sexes, all ages
Figure 10: United States Diagnostics Market Share, By Application, By Sexually Transmitted Diseases, By Value, 2016-2026F
Figure 11: Major Sexually Transmitted Diseases Cases Reported in the United States, As of 2019
Figure 12: United States Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 13: United States Hospital Market Size, By Value (USD Billion), 2016-2026F
Figure 14: United States Diagnostics Market Share, By Region, By Value, 2016-2026F
Figure 15: United States Diagnostics Market Share, By Company, By Value, 2020
Figure 16: United States Diagnostics Market Map, By Product Type, Market Size (USD Billion) & Growth Rate (%)
Figure 17: United States Diagnostics Market Map, By Type of Test, Market Size (USD Billion) & Growth Rate (%)
Figure 18: United States Diagnostics Market Map, By Technique, Market Size (USD Billion) & Growth Rate (%)
Figure 19: United States Diagnostics Market Map, By Usability, Market Size (USD Billion) & Growth Rate (%)
Figure 20: United States Infectious Disease Testing Market Size, By Value (USD Billion), 2016-2026F
Figure 21: Total Infectious Diseases Funding by National Institutes for Health (NIH), (USD Million)
Figure 22: United States Infectious Disease Testing Market Share, By Product Type, By Value, 2016-2026F
Figure 23: United States Infectious Disease Testing Market Share, By Technique, By Value, 2016-2026F
Figure 24: United States Infectious Disease Testing Market Share, By Usability, By Value, 2016-2026F
Figure 25: United States Infectious Disease Testing Market Share, By Application, By Value, 2016-2026F
Figure 26: United States Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 27: United States Infectious Disease Testing Market Share, By Region, By Value, 2016-2026F
Figure 28: United States Lipid Panel Test Market Size, By Value (USD Billion), 2016-2026F
Figure 29: United States National Health Expenditure As a Percentage of GDP
Figure 30: United States Lipid Panel Test Market Share, By Product Type, By Value, 2016-2026F
Figure 31: United States Lipid Panel Test Market Share, By Technique, By Value, 2016-2026F
Figure 32: United States Lipid Panel Test Market Share, By Usability, By Value, 2016-2026F
Figure 33: United States Lipid Panel Test Market Share, By Application, By Value, 2016-2026F
Figure 34: United States Lipid Panel Test Market Share, By End User, By Value, 2016-2026F
Figure 35: United States Lipid Panel Test Market Share, By Region, By Value, 2016-2026F
Figure 36: United States Metabolic Panel Test Market Size, By Value (USD Billion), 2016-2026F
Figure 37: United States Personal Health Care Expenditures (USD Trillion), 2012 - 2018
Figure 38: United States Metabolic Panel Test Market Share, By Product Type, By Value, 2016-2026F
Figure 39: United States Metabolic Panel Test Market Share, By Technique, By Value, 2016-2026F
Figure 40: United States Metabolic Panel Test Market Share, By Usability, By Value, 2016-2026F
Figure 41: United States Metabolic Panel Test Market Share, By Application, By Value, 2016-2026F
Figure 42: United States Metabolic Panel Test Market Share, By End User, By Value, 2016-2026F
Figure 43: Rates of Leading Causes of Death in United States in 2020 (per 100,000 Population)
Figure 44: United States Metabolic Panel Test Market Share, By Region, By Value, 2016-2026F
Figure 45: United States Population Ages 65 & Above (% of total population)
Figure 1: United States Diagnostics Market Size, By Value (USD Billion), 2016-2026F
Figure 2: United States Diagnostics Market Share, By Product Type, By Value, 2016-2026F
Figure 3: United States Diagnostics Market Share, By Type of Test, By Value, 2016-2026F
Figure 4: United States Diagnostics Market Share, By Technique, By Value, 2016-2026F
Figure 5: United States Diagnostics Market Share, By Usability, By Value, 2016-2026F
Figure 6: United States Diagnostics Market Share, By Application, By Value, 2016-2026F
Figure 7: United States Diagnostics Market Share, By Application, By Infectious Diseases, By Value, 2016-2026F
Figure 8: United States Diagnostics Market Share, By Application, By Cancer, By Value, 2016-2026F
Figure 9: New Cancer Cases Reported in the United States in 2020, both sexes, all ages
Figure 10: United States Diagnostics Market Share, By Application, By Sexually Transmitted Diseases, By Value, 2016-2026F
Figure 11: Major Sexually Transmitted Diseases Cases Reported in the United States, As of 2019
Figure 12: United States Diagnostics Market Share, By End User, By Value, 2016-2026F
Figure 13: United States Hospital Market Size, By Value (USD Billion), 2016-2026F
Figure 14: United States Diagnostics Market Share, By Region, By Value, 2016-2026F
Figure 15: United States Diagnostics Market Share, By Company, By Value, 2020
Figure 16: United States Diagnostics Market Map, By Product Type, Market Size (USD Billion) & Growth Rate (%)
Figure 17: United States Diagnostics Market Map, By Type of Test, Market Size (USD Billion) & Growth Rate (%)
Figure 18: United States Diagnostics Market Map, By Technique, Market Size (USD Billion) & Growth Rate (%)
Figure 19: United States Diagnostics Market Map, By Usability, Market Size (USD Billion) & Growth Rate (%)
Figure 20: United States Infectious Disease Testing Market Size, By Value (USD Billion), 2016-2026F
Figure 21: Total Infectious Diseases Funding by National Institutes for Health (NIH), (USD Million)
Figure 22: United States Infectious Disease Testing Market Share, By Product Type, By Value, 2016-2026F
Figure 23: United States Infectious Disease Testing Market Share, By Technique, By Value, 2016-2026F
Figure 24: United States Infectious Disease Testing Market Share, By Usability, By Value, 2016-2026F
Figure 25: United States Infectious Disease Testing Market Share, By Application, By Value, 2016-2026F
Figure 26: United States Infectious Disease Testing Market Share, By End User, By Value, 2016-2026F
Figure 27: United States Infectious Disease Testing Market Share, By Region, By Value, 2016-2026F
Figure 28: United States Lipid Panel Test Market Size, By Value (USD Billion), 2016-2026F
Figure 29: United States National Health Expenditure As a Percentage of GDP
Figure 30: United States Lipid Panel Test Market Share, By Product Type, By Value, 2016-2026F
Figure 31: United States Lipid Panel Test Market Share, By Technique, By Value, 2016-2026F
Figure 32: United States Lipid Panel Test Market Share, By Usability, By Value, 2016-2026F
Figure 33: United States Lipid Panel Test Market Share, By Application, By Value, 2016-2026F
Figure 34: United States Lipid Panel Test Market Share, By End User, By Value, 2016-2026F
Figure 35: United States Lipid Panel Test Market Share, By Region, By Value, 2016-2026F
Figure 36: United States Metabolic Panel Test Market Size, By Value (USD Billion), 2016-2026F
Figure 37: United States Personal Health Care Expenditures (USD Trillion), 2012 - 2018
Figure 38: United States Metabolic Panel Test Market Share, By Product Type, By Value, 2016-2026F
Figure 39: United States Metabolic Panel Test Market Share, By Technique, By Value, 2016-2026F
Figure 40: United States Metabolic Panel Test Market Share, By Usability, By Value, 2016-2026F
Figure 41: United States Metabolic Panel Test Market Share, By Application, By Value, 2016-2026F
Figure 42: United States Metabolic Panel Test Market Share, By End User, By Value, 2016-2026F
Figure 43: Rates of Leading Causes of Death in United States in 2020 (per 100,000 Population)
Figure 44: United States Metabolic Panel Test Market Share, By Region, By Value, 2016-2026F
Figure 45: United States Population Ages 65 & Above (% of total population)
